Amalgamated Financial’s Evolent Health EVH Stock Holding History

Amalgamated Financial’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$333K	Buy	+10,298	New	+$270K	﹤0.01%	1688

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Amalgamated Financial's EVH Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Evolent Health (EVH) in Q1 2022: 10,298 shares worth $333K. The stake represents ﹤0.01% of the portfolio and ranks #1688 among its holdings.

218 funds tracked by Wall St. Rank hold EVH as of Q1 2022.

Amalgamated Financial held 10,298 shares of Evolent Health worth $333K as of Q1 2022.
Evolent Health was a new Amalgamated Financial position in Q1 2022.
Evolent Health made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1688 holding.
218 funds tracked by Wall St. Rank held Evolent Health as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.